GSK To Build INR8.64bn Manufacturing Plant

News: UK drugmaker GlaxoSmithKline (GSK) will build a INR8.64bn (US$137mn) manufacturing plant for medicines in India. The move is part of the company's commitment of ascertaining improved access to quality medicines for people in the country. The construction of the manufacturing plant is expected to generate around 250 jobs in the country. The new facility, which is scheduled to become operational by 2017, will consist of a warehouse, site infrastructure and utilities for supporting the production and packaging of medicines.

GSK To Build INR8.64bn Manufacturing Plant

News: UK drugmaker GlaxoSmithKline (GSK) will build a INR8.64bn (US$137mn) manufacturing plant for medicines in India. The move is part of the company's commitment of ascertaining improved access to quality medicines for people in the country. The construction of the manufacturing plant is expected to generate around 250 jobs in the country. The new facility, which is scheduled to become operational by 2017, will consist of a warehouse, site infrastructure and utilities for supporting the production and packaging of medicines.

×

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

×

REQUEST A DEMO

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.

Thank you for your interest

A member of the team will be in touch shortly to arrange a convenient time for your free demonstration and trial. If your enquiry is urgent, please email our Client Services team here.